Name: Risk-Based Monitoring and Fraud Detection in Clinical Trials Using JMP and SAS (en Inglés)
Price: 1299.37 MXN
Availability: InStock
Author: Zink, Richard C.
ISBN: 9781612909912

Envío gratis

portada Risk-Based Monitoring and Fraud Detection in Clinical Trials Using JMP and SAS (en Inglés)

Formato

Libro Físico

Autor

Richard C. Zink

Editorial

SAS Institute

Idioma

Inglés

N° páginas

268

Encuadernación

Tapa Blanda

Dimensiones

23.5 x 19.1 x 1.4 cm

Peso

0.47 kg.

ISBN13

9781612909912

Categorías

Probabilidad y estadística
Software de matemáticas y estadísticas

Risk-Based Monitoring and Fraud Detection in Clinical Trials Using JMP and SAS (en Inglés)

Richard C. Zink (Autor) · SAS Institute · Tapa Blanda

Libro Físico

$ 1,299.37

$ 2,362.49

Ahorras: $ 1,063.12

45% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Lunes 17 de Junio y el Viernes 28 de Junio.

Lo recibirás en cualquier lugar de México entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Risk-Based Monitoring and Fraud Detection in Clinical Trials Using JMP and SAS (en Inglés)"

International guidelines recommend that clinical trial data should be actively reviewed or monitored; the well-being of trial participants and the validity and integrity of the final analysis results are at stake. Risk-based monitoring (RBM) makes use of central computerized review of clinical trial data and site metrics to determine if and when clinical sites should receive more extensive quality review or intervention. Risk-Based Monitoring and Fraud Detection in Clinical Trials Using JMP and SAS describes analyses for RBM that incorporate and extend the recommendations of TransCelerate Biopharm Inc., methods to detect potential patient-or investigator misconduct, snapshot comparisons to more easily identify new or modified data, and other novel visual and analytical techniques to enhance safety and quality reviews. The analytical methods described enable the clinical trial team to take a proactive approach to data quality and safety to streamline clinical development activities and address shortcomings while the study is ongoing.